Larvol Delta - AGNES19-Adrecizumab-HAM8101-to-Improve-Prognosis-and-Outcomes-in-COVID19-Trial

enibarcimab (HAM8101) - Adrenomed

http://clinicaltrials.gov/ct2/show/NCT05156671

Oct 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next